CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 206 enrolled
Drug / intervention
Trevo Thrombectomy Procedure +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02142283
NCT02142283N/ACompleted
CompareCT.gov

Diffusion Weighted Imaging (DWI) or Computerized Tomography Perfusion (CTP) Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention (DAWN)

Stryker Neurovascular·interventional·Posted May 20, 2014·Updated Jul 20, 2018

In Brief

A clinical study evaluating Trevo Thrombectomy Procedure and Medical Management for Ischemic Stroke. Completed, enrolled 206 participants across 32 sites in 5 countries.

Detailed Summary

The purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical management alone in appropriately selected subjects experiencing an acute ischemic stroke when treatment is initiated within 6-24 hours after last seen well.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesAustralia, Canada, France, Spain, United States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 20, 2014
Enrollment StartJul 1, 2014
Primary CompletionMay 15, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.1 years ago

Interventions

Trevo Thrombectomy Proceduredevice

stent retriever; intended to restore blood flow in the neurovasculature by removing thrombus (clot)

Medical Managementother

Standard of Care not including mechanical thrombectomy, no intra arterial treatment, may include aspirin, therapy etc